HRS9531 Tablet

DRUG3 trials

Sponsors

Fujian Shengdi Pharmaceutical Co., Ltd.

Conditions

Chronic Management of Body WeightT2DM

Phase 2

Efficacy and Safety of HRS9531 Tablet in Obese Subjects

CompletedNCT06841445

Fujian Shengdi Pharmaceutical Co., Ltd.Chronic Management of Body Weight

Start: 2025-04-07End: 2026-01-08Updated: 2026-04-03

A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus

RecruitingNCT07599410

Fujian Shengdi Pharmaceutical Co., Ltd.T2DM

Start: 2026-07-14End: 2027-07-01Target: 240Updated: 2026-07-23

Phase 3

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

RecruitingNCT07670884

Fujian Shengdi Pharmaceutical Co., Ltd.Chronic Management of Body Weight

Start: 2026-07-24End: 2027-11-30Target: 675Updated: 2026-08-13